About Current Viruses and Treatment Methodologies
A peer-reviewed, open access journal advancing virology research from molecular mechanisms to antiviral strategies — connecting virologists, microbiologists, and translational researchers across six continents.
Accelerating Viral Discovery and Therapeutic Innovation
The Journal of Current Viruses and Treatment Methodologies (JVAT) (ISSN 2691-8862) publishes rigorous, peer-reviewed research that deepens understanding of viral biology, pathogenesis, evolution, and host-virus interactions. As a COPE-aligned, open access journal published by Open Access Pub, JVAT provides a global platform for scientists investigating viral mechanisms, developing antiviral compounds, engineering vaccines, and characterizing viral diversity across ecosystems.
Our editorial mission centers on three principles: scientific excellence through expert peer review, rapid dissemination that accelerates translational applications, and barrier-free access via Creative Commons Attribution (CC BY 4.0) licensing. We unite virologists, molecular biologists, immunologists, structural biologists, and bioinformaticians who work at the intersection of basic virology and therapeutic development.
JVAT welcomes original research articles, systematic reviews, methodological papers, and brief communications that advance mechanistic knowledge, identify novel viral targets, or validate antiviral strategies across RNA viruses, DNA viruses, retroviruses, and emerging viral pathogens.
Virology demands precision — from characterizing replication machinery to quantifying neutralizing antibody responses. JVAT serves researchers who require a publication partner that balances rigorous peer review with publication speed, ethical oversight with methodological transparency, and niche specialization with interdisciplinary reach.
Our editorial board comprises experts in viral genetics, structural virology, antiviral drug discovery, vaccine immunology, viral ecology, and bioinformatics. Each submission receives structured evaluation that examines experimental design, data reproducibility, mechanistic interpretation, and translational potential. Accepted manuscripts are enriched with DOI registration, indexing metadata, and visual abstracts to maximize discoverability and citation impact.
JVAT publishes mechanistic virology research, therapeutic discovery, and translational studies that clarify how viruses replicate, evade immunity, and respond to interventions. We prioritize manuscripts that integrate molecular techniques, structural biology, genomics, and immunology to advance fundamental knowledge and therapeutic innovation.
Viral Replication and Pathogenesis
Genome replication mechanisms, transcription regulation, protein processing, assembly pathways, and virulence determinants across viral families.
Host-Virus Interactions
Cellular entry mechanisms, innate immunity evasion, interferon antagonism, autophagy modulation, and host factor dependencies.
Antiviral Drug Discovery
Small molecule inhibitors, polymerase inhibitors, protease targeting, host-directed therapies, drug resistance mechanisms, and structure-activity relationships.
Vaccine Development
Immunogen design, adjuvant optimization, neutralizing antibody induction, T cell responses, viral vector platforms, and mRNA vaccine technologies.
Viral Evolution and Diversity
Mutation rates, recombination events, quasispecies dynamics, emergence patterns, zoonotic transmission, and phylogenetic analysis.
Diagnostic and Detection Methods
PCR assays, sequencing platforms, serology techniques, point-of-care diagnostics, biosensors, and viral load quantification.
Structural Virology
Capsid architecture, envelope glycoprotein structures, polymerase complexes, cryo-EM analysis, and structural basis of neutralization.
Viral Immunology
Antibody responses, cellular immunity, immune escape variants, immunopathology, and correlates of protection.
Emerging and Re-emerging Viruses
Novel pathogen characterization, outbreak investigation, spillover events, pandemic preparedness, and one-health approaches.
JVAT's editorial leadership ensures that manuscripts are evaluated by specialists with deep expertise in viral systems, experimental methodologies, and translational research. Our editorial board spans virology research centers, pharmaceutical companies, public health institutes, and academic laboratories across five continents.
View complete editorial profiles and research interests at the JVAT Editorial Board page.
Every submission undergoes single-blind peer review by specialists in viral biology, biochemistry, or related disciplines. Reviewers assess experimental design, methodological rigor, data interpretation, reproducibility, and mechanistic insight. Authors receive detailed feedback that strengthens manuscripts regardless of publication outcome.
- Methodological Evaluation: Reviewers scrutinize viral assays, molecular techniques, structural analyses, statistical methods, and controls to ensure experimental validity.
- Ethical Compliance: Manuscripts must document biosafety approvals, ethics clearances, and adherence to relevant guidelines (e.g., WHO laboratory biosafety standards).
- Transparency Standards: Plagiarism screening via iThenticate, conflict of interest disclosure, funding acknowledgment, and data availability statements are required.
- Rapid Communication: Editorial decisions are communicated within 14 days of review completion, with clear revision guidance and resubmission timelines.
JVAT's submission workflow is designed for efficiency and clarity. Authors submit manuscripts through the online submission portal or via email to [email protected]. Our editorial team acknowledges submissions within 72 hours and provides updates at each review milestone.
Prepare Manuscript
Review Aims & Scope and Instructions for Authors to ensure compliance with formatting, reporting, and ethics standards.
Submit Online
Upload manuscript, figures, supplementary data, and ethics documentation via the submission system or email. Include a cover letter summarizing novelty and compliance.
Peer Review
Manuscripts undergo evaluation by specialist reviewers. Authors receive feedback within 14 days and can submit revisions with point-by-point responses.
Publication
Accepted manuscripts are copyedited, proofed (48-hour author review), and published online within 3 days of approval. Articles receive DOI assignment and indexing metadata.
JVAT operates under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. Authors retain copyright, enabling unrestricted reuse for teaching, translation, data mining, and derivative works with proper attribution. This model ensures global accessibility and accelerates scientific progress.
Article processing charges (APCs) apply only after acceptance. View pricing, waiver eligibility, and institutional agreements on the APC information page. Early-career researchers, investigators from low-resource settings, and unfunded studies may qualify for discretionary support — contact [email protected] to discuss options.
JVAT articles are distributed through academic search engines, subject repositories, and citation databases to maximize researcher access and citation potential.
- Google Scholar, Semantic Scholar, ResearchGate, Academia.edu
- Crossref DOI registration for persistent identification
- Directory of Open Access Journals (DOAJ) application in progress
- Scilit, CiteFactor, ResearchBib, and discipline-specific virology indexes
- Institutional repositories and library discovery systems
Authors can track article metrics, citations, and altmetrics through the JVAT website and author dashboards provided by Open Access Pub.
Publish Your Virology Research with JVAT
Whether you're characterizing novel viral mechanisms, validating antiviral targets, or engineering next-generation vaccines, JVAT provides a trusted publication venue with rigorous peer review, rapid turnaround, and global visibility.
